Cargando…
Repurposing drugs targeting the P2X7 receptor to limit hyperinflammation and disease during influenza virus infection
BACKGROUND AND PURPOSE: Severe influenza A virus (IAV) infections are associated with damaging hyperinflammation that can be fatal. There is an urgent need to identify new therapeutic agents to treat severe and pathogenic IAV infections. Repurposing of drugs with an existing and studied pharmacokine...
Autores principales: | Rosli, Sarah, Kirby, Francis J., Lawlor, Kate E., Rainczuk, Kate, Drummond, Grant R., Mansell, Ashley, Tate, Michelle D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780046/ https://www.ncbi.nlm.nih.gov/pubmed/31271646 http://dx.doi.org/10.1111/bph.14787 |
Ejemplares similares
-
Gasdermin D promotes hyperinflammation and immunopathology during severe influenza A virus infection
por: Rosli, Sarah, et al.
Publicado: (2023) -
COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs
por: TUFAN, Abdurrahman, et al.
Publicado: (2020) -
In Vivo Infection Model of Severe Influenza A Virus
por: Mansell, Ashley, et al.
Publicado: (2017) -
Interleukin‐1β exacerbates disease and is a potential therapeutic target to reduce pulmonary inflammation during severe influenza A virus infection
por: Bawazeer, Abdulah OS, et al.
Publicado: (2021) -
Die Another Way: Interplay between Influenza A Virus, Inflammation and Cell Death
por: Laghlali, Gabriel, et al.
Publicado: (2020)